Interactions among Interleukin-6, C-Reactive Protein and Interleukin-6 (-174) G/C Polymorphism in the Pathogenesis of Crohn’s Disease and Ulcerative Colitis
| Autor: | Silvio Mihaljević, Boris Takač, Ljubica Glavaš-Obrovac, Mario Štefanić, Ines Rajkovac, Mirjana Suver-Stević, Marko Samardžija, Silvija Canecki-Varžić, Aleksandar Kibel, Damir Kovač |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Crohn’s disease
030213 general clinical medicine 0209 industrial biotechnology medicine.medical_specialty lcsh:Medicine Single-nucleotide polymorphism 02 engineering and technology Inflammatory bowel diseases Gastroenterology Inflammatory bowel disease Colitis ulcerative C-reactive protein Pathogenesis 03 medical and health sciences 020901 industrial engineering & automation 0302 clinical medicine Crohn Disease Internal medicine medicine Humans Original Scientific Papers Interleukin 6 Crohn's disease Polymorphism Genetic biology business.industry Interleukin-6 Polymorphism single nucleotide lcsh:R General Medicine medicine.disease Ulcerative colitis digestive system diseases Cross-Sectional Studies Case-Control Studies biology.protein Gene polymorphism business |
| Zdroj: | Acta Clinica Croatica, Vol 59, Iss 1., Pp 67-80 (2020) Acta Clinica Croatica |
| ISSN: | 1333-9451 0353-9466 |
| Popis: | Inflammatory bowel diseases are multifactorial disorders the clinical manifestation of which depends on the interaction among immune response, genetic and environmental factors. There is growing evidence that cytokines and gene polymorphisms have an important role in disease pathogenesis in various populations although molecular mechanism of their signaling and interactions is not fully understood yet. The present study aimed at exploring the effects of interleukin- 6, C-reactive protein and interleukin-6 rs1800795 polymorphism on the development of Crohn’s disease, ulcerative colitis and inflammatory bowel diseases overall and at determining differences between inflammatory bowel disease patients and healthy controls. A total of 132 inflammatory bowel disease patients and 71 healthy blood donors were investigated. In order to assess the clinical relevance of interleukin- 6 and C- reactive protein serum concentration and interleukin-6 rs1800795 single nucleotide polymorphism in patients with Crohn’s disease and ulcerative colitis, we performed a cross- sectional, case-control study. Quantitative assessment of serum interleukin-6 and C- reactive protein was performed with solid- phase, enzyme-labeled, chemiluminescent sequential immunometric and immunoturbidimetric assay, respectively. A real-time fluorescence resonance energy transfer-based method on a LightCyclerTM PCR 1.2 was used for genotyping of IL-6 rs1800795 polymorphism. Both interleukin- 6 and C-reactive protein serum levels were elevated in Crohn’s disease and ulcerative colitis patients. Positive correlations were observed between C-reactive protein and interleukin-6 serum concentration and ulcerative colitis activity index as measured by modified Truelove-Witt’s severity index scale. C-reactive protein serum level was higher in Crohn’s disease patients without intestinal resection than in Crohn’s disease patients with prior intestinal resection. In ulcerative colitis patients, interleukin- 6 and C-reactive protein serum levels were statistically significantly higher in CC interleukin- 6 genotype in comparison to GG+GC genotype. Analysis of the promoter region of the interleu-kin-6 rs1800795 gene polymorphism showed no statistically significant difference in allele frequency either between inflammatory bowel disease patients and healthy controls or between the two inflammatory bowel disease phenotypes and healthy controls. Associations presented in this study give a potentially important insight into the role of interleukin- 6 and C-reactive protein signaling and interleukin-6 polymorphism in the pathogenesis of Crohn’s disease and ulcerative colitis disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|